Morten Karsdal
Morten Karsdal
Professor
Geverifieerd e-mailadres voor nordicbioscience.com
Titel
Geciteerd door
Geciteerd door
Jaar
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation
P Garnero, M Ferreras, MA Karsdal, R Nicamhlaoibh, J Risteli, O Borel, ...
Journal of bone and Mineral Research 18 (5), 859-867, 2003
4972003
Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use
VB Kraus, FJ Blanco, M Englund, MA Karsdal, LS Lohmander
Osteoarthritis and cartilage 23 (8), 1233-1241, 2015
3962015
Republished: Value of biomarkers in osteoarthritis: current status and perspectives
M Lotz, J Martel-Pelletier, C Christiansen, ML Brandi, O Bruyère, ...
Postgraduate medical journal 90 (1061), 171-178, 2014
3502014
Local communication on and within bone controls bone remodeling
K Henriksen, AV Neutzsky-Wulff, LF Bonewald, MA Karsdal
Bone 44 (6), 1026-1033, 2009
3222009
Matrix metalloproteinase-dependent activation of latent transforming growth factor-β controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis
MA Karsdal, L Larsen, MT Engsig, H Lou, M Ferreras, A Lochter, ...
Journal of Biological Chemistry 277 (46), 44061-44067, 2002
2792002
Proteinases in bone resorption: obvious and less obvious roles
JM Delaissé, MT Engsig, V Everts, M del Carmen Ovejero, M Ferreras, ...
Clinica Chimica Acta 291 (2), 223-234, 2000
2572000
Are nonresorbing osteoclasts sources of bone anabolic activity?
MA Karsdal, TJ Martin, J Bollerslev, C Christiansen, K Henriksen
Journal of bone and mineral research 22 (4), 487-494, 2007
2562007
The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?
F Genovese, AA Manresa, DJ Leeming, MA Karsdal, P Boor
Fibrogenesis & tissue repair 7 (1), 1-14, 2014
2552014
The future of blood-based biomarkers for Alzheimer's disease
K Henriksen, SE O’Bryant, H Hampel, JQ Trojanowski, TJ Montine, ...
Alzheimer's & Dementia 10 (1), 115-131, 2014
2502014
Should subchondral bone turnover be targeted when treating osteoarthritis?
MA Karsdal, DJ Leeming, EB Dam, K Henriksen, P Alexandersen, ...
Osteoarthritis and cartilage 16 (6), 638-646, 2008
2462008
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ...
The lancet Respiratory medicine 3 (6), 462-472, 2015
2232015
Extracellular matrix remodeling: the common denominator in connective tissue diseases possibilities for evaluation and current understanding of the matrix as more than a …
MA Karsdal, MJ Nielsen, JM Sand, K Henriksen, F Genovese, ...
Assay and drug development technologies 11 (2), 70-92, 2013
2212013
Osteoclast activity and subtypes as a function of physiology and pathology—implications for future treatments of osteoporosis
K Henriksen, J Bollerslev, V Everts, MA Karsdal
Endocrine reviews 32 (1), 31-63, 2011
2122011
The disease modifying osteoarthritis drug (DMOAD): is it in the horizon?
P Qvist, AC Bay-Jensen, C Christiansen, EB Dam, P Pastoureau, ...
Pharmacological research 58 (1), 1-7, 2008
1972008
Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future
MA Karsdal, M Michaelis, C Ladel, AS Siebuhr, AR Bihlet, JR Andersen, ...
Osteoarthritis and cartilage 24 (12), 2013-2021, 2016
1932016
Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity
MA Karsdal, SH Madsen, C Christiansen, K Henriksen, AJ Fosang, ...
Arthritis research & therapy 10 (3), 1-12, 2008
1932008
Molecular serum markers of liver fibrosis
T Liu, X Wang, MA Karsdal, DJ Leeming, F Genovese
Biomarker insights 7, BMI. S10009, 2012
1892012
The good and the bad collagens of fibrosis–their role in signaling and organ function
MA Karsdal, SH Nielsen, DJ Leeming, LL Langholm, MJ Nielsen, ...
Advanced drug delivery reviews 121, 43-56, 2017
1852017
RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism
K Henriksen, M Karsdal, JM Delaissé, MT Engsig
Journal of Biological Chemistry 278 (49), 48745-48753, 2003
1782003
A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope …
N Barascuk, SS Veidal, L Larsen, DV Larsen, MR Larsen, J Wang, ...
Clinical biochemistry 43 (10-11), 899-904, 2010
1772010
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20